603882 金域醫學
按盤價 
30.640 +0.530 (+1.760%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -1.125 | -4.860 | 7.571 | 36.885 | 43.992 |
| 總資產報酬率 ROA (%) | -0.792 | -3.441 | 5.015 | 22.357 | 25.527 |
| 投入資產回報率 ROIC (%) | -1.004 | -4.424 | 6.975 | 33.452 | 38.736 | 邊際利潤分析 |
| 銷售毛利率 (%) | 34.821 | 33.146 | 36.478 | 43.128 | 47.292 |
| 營業利潤率 (%) | -1.388 | -3.801 | 8.897 | 21.628 | 23.250 |
| 息稅前利潤/營業總收入 (%) | -1.836 | -6.140 | 8.657 | 21.376 | 23.090 |
| 淨利潤/營業總收入 (%) | -1.957 | -5.768 | 7.458 | 18.383 | 19.790 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | -311.198 | -100.489 | 122.168 | 106.417 | 101.367 |
| 價值變動淨收益/利潤總額(%) | -4.455 | 15.475 | 35.522 | -0.325 | -0.266 |
| 營業外收支淨額/利潤總額(%) | 23.273 | 37.707 | -2.631 | -0.798 | -1.063 | 償債能力分析 |
| 流動比率 (X) | 3.141 | 3.278 | 3.073 | 2.327 | 2.127 |
| 速動比率 (X) | 3.052 | 3.189 | 2.981 | 2.239 | 2.035 |
| 資產負債率 (%) | 28.414 | 28.068 | 27.365 | 36.104 | 39.330 |
| 帶息債務/全部投入資本 (%) | 9.524 | 8.121 | 4.966 | 4.747 | 7.664 |
| 股東權益/帶息債務 (%) | 930.401 | 1,105.756 | 1,855.251 | 1,940.682 | 1,158.661 |
| 股東權益/負債合計 (%) | 247.395 | 251.139 | 259.693 | 172.122 | 149.086 |
| 利息保障倍數 (X) | 70.156 | 159.115 | -701.395 | -263.228 | 273.356 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 244.621 | 243.646 | 260.537 | 135.972 | 110.923 |
| 存貨周轉天數 (天) | 17.751 | 16.722 | 21.684 | 15.346 | 16.678 |
| 備註： | 即時報價更新時間為 14/11/2025 14:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
